The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Credit Facility to TP Group

16 Dec 2021 10:30

RNS Number : 9018V
Science Group PLC
16 December 2021
 

 

 

 

16 December 2021

 

Science Group plc ("Science Group")

 

Credit Facility to TP Group

 

 

 

 

Following the appointment of the two Science Group nominees to the TP Group plc ("TP Group") Board, Science Group supports the new strategy set out by TP Group on 1 November 2021 which is consistent with the model outlined in the Science Group strategic investment.

 

From the outset, Science Group consistently highlighted to TP Group both the benefits of a potential partnership and the potential challenges as an independent entity. In particular, over the summer, Science Group noted the going concern commentary in the TP Group 2020 Annual Report. To mitigate certain risks and provide a more robust financial platform, Science Group recently offered, and the independent directors of TP Group have accepted, a standby revolving credit facility (the "Facility"). It is not certain that the Facility will be required but it provides additional headroom to allow the TP Group Board to execute its new strategy.

 

The Facility is for up to £5 million for the period from the date of signing until 30 September 2023. The Facility, which is unsecured, includes an arrangement fee of 3%, interest rate on drawn amounts of 1% per month and a rate of 0.4% per month of any undrawn amount, both subject to Sterling Overnight Index Average (SONIA) remaining below 1%. The Facility can be cancelled or refinanced by TP Group with a third party at any time and without penalty or early termination charges but while in place the terms of the agreement protect Science Group from material shareholder or board dilution. As a result of the Science Group facility being provided, TP Group's bank has amended and eased covenants and extended the existing bank loan to 30 September 2023.

 

As directors of both companies, Martyn Ratcliffe and Peter Bertram have not participated in any decisions of the Boards of either TP Group nor Science Group in relation to the Facility.

 

 

End

 

Science Group plc

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

Nick Adams, Alex Price

Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Joint Broker)

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFIFALRLIL
Date   Source Headline
31st Jul 20174:50 pmRNSHolding(s) in Company
31st Jul 201711:25 amRNSHolding(s) in Company
31st Jul 20178:10 amRNSHoldings in Company
28th Jul 201711:07 amRNSDirectors' Dealings
28th Jul 20178:07 amRNSTrading Update and Completion of Fundraising
27th Jul 201711:46 amRNSResult of General Meeting and Issue of Equity
27th Jul 20177:00 amRNSResult of Open Offer
25th Jul 20177:00 amRNSNotice of Half-Year Results
24th Jul 20177:00 amRNS£1.9m Export Defence Contract Award
10th Jul 201712:45 pmRNSPublication of Circular
10th Jul 20177:00 amRNSConditional Fundraising
22nd Jun 20177:00 amRNSTP Group admitted to Defence Services Framework
25th May 20172:00 pmRNSResult of AGM
25th May 20177:00 amRNSAGM Statement
9th May 201711:45 amRNSReplacement and grant of share options
4th May 20177:00 amRNSContract Update
11th Apr 201712:00 pmRNSConfirmation of contract award
11th Apr 20177:00 amRNSPublication of Annual Report and Notice of AGM
6th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSFinal Results
3rd Apr 20177:00 amRNSConfirmation of contract award
2nd Mar 20175:45 pmRNSAppointment of Non-Executive Director -Replacement
27th Feb 20177:00 amRNSAppointment of Non-Executive Director
21st Feb 20177:00 amRNSBoard Appointment
16th Feb 20174:40 pmRNSHoldings in Company
7th Feb 20177:00 amRNSAcquisition
25th Jan 20177:00 amRNSTrading Update and Notice of Results
16th Dec 201610:00 amRNSHolding(s) in Company
15th Dec 20167:00 amRNSBoard Change
14th Dec 20167:00 amRNSTrading Update
6th Dec 201611:23 amRNSContract Win
29th Nov 201610:30 amRNSTPG secures BAE Systems contract
24th Nov 20161:00 pmRNSHolding(s) in Company
12th Oct 20167:00 amRNSContract win
28th Sep 20163:00 pmRNSCapital Reduction Effective
13th Sep 20167:00 amRNSContract win
13th Sep 20167:00 amRNSInterim Report for six months ended 30 June 2016
8th Sep 201610:49 amRNSResult of General Meeting
31st Aug 20167:00 amRNSContract Win
19th Aug 20167:00 amRNSProposed Reduction of Capital and Notice of GM
5th Aug 201611:45 amRNSContract update
20th Jul 20167:00 amRNSContract Award
13th Jul 20167:00 amRNSTrading Update and Notice of Half-Year Results
4th Jul 20163:00 pmRNSContract update
30th Jun 20162:45 pmRNSDirector/PDMR Shareholding
21st Jun 201611:00 amRNSDirector/PDMR Shareholding
21st Jun 20167:00 amRNSDirector/PDMR Shareholding
17th Jun 20167:00 amRNSBoard Change
14th Jun 201611:45 amRNSResult of AGM
18th May 20164:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.